Check-Cap Ltd.
MBAIHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframeHeadquartered within the healthcare sector, Check-Cap Ltd. focuses on Diagnostics & Research services and products. Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology for the detection of precancerous colorectal polyps. The $7.9M market capitalization puts MBAI squarely in micro-cap range for its industry.
Market Cap
$7.9M
Beta
0.79
P/E (TTM)
1.46
P/E (Fwd)
—
EPS (TTM)
$0.70
EPS (Fwd)
—
ROE
416.7%
ROA
-37.7%
Cash
$219,000
Total Debt
$16,000
Free CF
$846,875
52W Change
34.3%
Annual Financials
Cash vs Debt
Where MBAI stands vs its 150-day and 200-day moving averages
As of the July 14, 2026 close, MBAI finished 31.10% below its 150-day moving average ($1.64) and 32.34% below its 200-day moving average ($1.67). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is MBAI overbought or oversold?
At the July 14, 2026 close, MBAI's RSI(14) was 33.7, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Check-Cap Ltd. holds $219K in cash against $16K in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow comes in at $847K, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 416.7% points to exceptionally high capital efficiency, indicating how much profit the company produces per dollar of shareholder equity.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing MBAI.